Mapping mouse IL‐13 binding regions using structure modeling, molecular docking, and high‐density peptide microarray analysis
Satish K. Madala(University of Cincinnati Medical Center), Thomas A. Wynn(National Institute of Allergy and Infectious Diseases), Mark S. Wilson(Gene Therapy Laboratory), Deepak Sharma(National Institutes of Health), Michael Dolan(National Institutes of Health), Daniel C. Masison(National Institutes of Health), Thirumalai R. Ramalingam(National Institutes of Health), Margaret Mentink‐Kane(National Institutes of Health)
Cited by 8
Related Papers
Type 2 immunity in tissue repair and fibrosis
|Nature reviews. Immunology|2017|1.1k
Pulmonary fibrosis: pathogenesis, etiology and regulation
|Mucosal Immunology|2009|834
Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
|PLoS Pathogens|2009|808
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
|The Journal of Experimental Medicine|2010|740